Although some studies have attributed this cognitive decline to comorbidities such as sleep apnea, cerebral microbleeds, or diabetes [3, 31, 32], recent evidence has implicated the direct involvement of elevated GH and IGF‐1 levels. The gene discussed is GH1; the disease is cerebral microbleeds.